Acinetobacter baumannii during COVID-19: What Is the Real Pandemic?
Conflicts of Interest
References
- Puzniak, L.; Bauer, K.A.; Yu, K.C.; Moise, P.; Finelli, L.; Ye, G.; De Anda, C.; Vankeepuram, L.; Gupta, V. Effect of inadequate empiric antibacterial therapy on hospital outcomes in SARS-CoV-2-positive and -negative US patients with a positive bacterial culture: A multicenter evaluation from March to November 2020. Open Forum. Infect. Dis. 2021, 8, ofab232. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Wang, J.; Yang, Y.; Cai, P.; Cao, J.; Cai, X.; Zhang, Y. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: A retrospective analysis. Antimicrob. Resist. Infect. Control 2020, 9, 153. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Vidal, C.; Sanjuan, G.; Moreno-García, E.; Puerta-Alcalde, P.; Garcia-Pouton, N.; Chumbita, M.; Fernandez-Pittol, M.; Pitart, C.; Inciarte, A.; Bodro, M.; et al. Incidence of coinfections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study. Clin. Microbiol. Infect. 2021, 27, 83–88. [Google Scholar] [CrossRef] [PubMed]
- Langford, B.J.; So, M.; Raybardhan, S.; Leung, V.; Westwood, D.; MacFadden, D.R.; Jean-Paul, R.S.; Nick, D. Bacterial coinfection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020, 26, 1622–1629. [Google Scholar] [CrossRef] [PubMed]
- Ellis, R.C.; Roberts, E.K.; Grier, J.T.; Fiester, S.E. Acinetobacter baumannii infections that are resistant to treatment: Warning signs from the COVID-19 pandemic. Future Microbiol. 2022, 17, 1345–1347. [Google Scholar] [CrossRef] [PubMed]
- Giannitsioti, E.; Louka, C.; Mamali, V.; Kousouli, E.; Velentza, L.; Papadouli, V.; Loizos, G.; Mavroudis, P.; Kranidiotis, G.; Rekleiti, N.; et al. Bloodstream infections in a COVID-19 Non-ICU department: Microbial epidemiology, resistance profiles and comparative analysis of risk factors and patients’ outcome. Microorganisms 2022, 10, 1314. [Google Scholar] [CrossRef] [PubMed]
- Sathyakamala, R.; Peace, A.R.; Shanmugam, P. A comparative study on bacterial coinfections and prevalence of multidrug-resistant organisms among patients in COVID and Non-COVID Intensive Care Units. J. Prev. Med. Hyg. 2022, 63, E19–E26. [Google Scholar] [CrossRef] [PubMed]
- Clancy, C.J.; Schwartz, I.S.; Kula, B.; Nguyen, M.H. Bacterial superinfections among persons with coronavirus disease 2019: A comprehensive review of data from postmortem studies. Open Forum. Infect. Dis. 2021, 8, ofab065. [Google Scholar] [CrossRef] [PubMed]
- Vijay, S.; Bansal, N.; Rao, B.K.; Veeraraghavan, B.; Rodrigues, C.; Wattal, C.; Goyal, J.P.; Tadepalli, K.; Mathur, P.; Venkateswaran, R.; et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect. Drug Resist. 2021, 14, 1893–1903. [Google Scholar] [CrossRef] [PubMed]
- Boral, J.; Genç, Z.; Pınarlık, F.; Ekinci, G.; Kuskucu, M.A.; İrkören, P.; Kapmaz, M.; Tekin, S.; Çakar, N.; Şentürk, E.; et al. The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit. Sci. Rep. 2022, 12, 20808. [Google Scholar] [CrossRef] [PubMed]
- Bengoechea, J.A.; Bamford, C.G. SARS-CoV-2, bacterial coinfections, and AMR: The deadly trio in COVID-19? EMBO Mol. Med. 2020, 2, e12560. [Google Scholar] [CrossRef]
- Sreenath, K.; Batra, P.; Vinayaraj, E.V.; Bhatia, R.; SaiKiran, K.; Singh, V.; Singh, S.; Verma, N.; Singh, U.B.; Mohan, A.; et al. Coinfections with other respiratory pathogens among patients with COVID-19. Microbiol. Spectr. 2021, 9, e0016321. [Google Scholar] [CrossRef] [PubMed]
- Maes, M.; Higginson, E.; Pereira-Dias, J.; Curran, M.D.; Parmar, S.; Khokhar, F.; Cuchet-Lourenço, D.; Lux, J.; Sharma-Hajela, S.; Ravenhill, B.; et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit. Care 2021, 25, 25. [Google Scholar] [CrossRef] [PubMed]
- Pourajam, S.; Kalantari, E.; Talebzadeh, H.; Mellali, H.; Sami, R.; Soltaninejad, F.; Amra, B.; Sajadi, M.; Alenaseri, M.; Kalantari, F.; et al. Secondary bacterial infection and clinical characteristics in patients with COVID-19 Admitted to two intensive care units of an academic hospital in Iran during the first wave of the pandemic. Front. Cell Infect. Microbiol. 2022, 12, 784130. [Google Scholar] [CrossRef]
- Costa, R.L.D.; Lamas, C.D.C.; Simvoulidis, L.F.N.; Espanha, C.A.; Moreira, L.P.M.; Bonancim, R.A.B.; Weber, J.V.L.A.; Ramos, M.R.F.; Silva, E.C.F.; Oliveira, L.P. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: Impact of gram-negative bacterial resistance. Rev. Inst. Med. Trop. São Paulo 2022, 64, e6. [Google Scholar] [CrossRef] [PubMed]
- Bahceci, I.; Yildiz, I.E.; Duran, O.F.; Duran, O.F.; Soztanaci, U.S.; Harbawi, Z.K.; Senol, F.F.; Demiral, G. Secondary bacterial infection rates among patients with COVID-19. Cureus 2022, 14, e22363. [Google Scholar] [CrossRef] [PubMed]
- Ma, C.; Mcclean, S. Mapping global prevalence of Acinetobacter baumannii and recent vaccine development to tackle it. Vaccines 2021, 9, 570. [Google Scholar] [CrossRef] [PubMed]
- Rangel, K.; Chagas, T.P.G.; De-Simone, S.G. Acinetobacter baumannii infections in times of COVID-19 pandemic. Pathogens 2021, 10, 1006. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rangel, K.; De-Simone, S.G. Acinetobacter baumannii during COVID-19: What Is the Real Pandemic? Pathogens 2023, 12, 41. https://doi.org/10.3390/pathogens12010041
Rangel K, De-Simone SG. Acinetobacter baumannii during COVID-19: What Is the Real Pandemic? Pathogens. 2023; 12(1):41. https://doi.org/10.3390/pathogens12010041
Chicago/Turabian StyleRangel, Karyne, and Salvatore Giovanni De-Simone. 2023. "Acinetobacter baumannii during COVID-19: What Is the Real Pandemic?" Pathogens 12, no. 1: 41. https://doi.org/10.3390/pathogens12010041